Cargando…

USP15 stabilizes MDM2 to mediate cancer cell survival and inhibit antitumor T cell responses

Deubiquitinases (DUBs) represent a new class of drug targets, although the physiological function of only few DUBs has been characterized. Here we identified the DUB USP15 as a crucial negative regulator of T cell activation. USP15 stabilized an E3 ubiquitin ligase, MDM2, which in turn negatively re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zou, Qiang, Jin, Jin, Hu, Hongbo, Li, Haiyan S., Romano, Simona, Xiao, Yichuan, Nakaya, Mako, Zhou, Xiaofei, Cheng, Xuhong, Yang, Peirong, Lozano, Guillermina, Zhu, Chengming, Watowich, Stephanie S., Ullrich, Stephen E, Sun, Shao-Cong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2014
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4032322/ https://www.ncbi.nlm.nih.gov/pubmed/24777531 http://dx.doi.org/10.1038/ni.2885

Ejemplares similares

The kinase TBK1 functions in dendritic cells to regulate T cell homeostasis, autoimmunity, and antitumor immunity
por: Xiao, Yichuan, et al.
Publicado: (2017)

TPL2 mediates autoimmune inflammation through activation of the TAK1 axis of IL-17 signaling
por: Xiao, Yichuan, et al.
Publicado: (2014)

FKBP51 employs both scaffold and isomerase functions to promote NF-κB activation in melanoma
por: Romano, Simona, et al.
Publicado: (2015)

Mdm proteins: critical regulators of embryogenesis and homoeostasis
por: Moyer, Sydney M., et al.
Publicado: (2017)

T cell development involves TRAF3IP3-mediated ERK signaling in the Golgi
por: Zou, Qiang, et al.
Publicado: (2015)

Ubc13 maintains the suppressive function of regulatory T cells and prevents their conversion into effector-like T cells
por: Chang, Jae-Hoon, et al.
Publicado: (2012)

Tumorigenesis promotes Mdm4-S overexpression
por: Pant, Vinod, et al.
Publicado: (2017)

Augmented antitumor activity of 5‐fluorouracil by double knockdown of MDM4 and MDM2 in colon and gastric cancer cells
por: Imanishi, Mamiko, et al.
Publicado: (2019)

Peli1 negatively regulates type I interferon induction and antiviral immunity in the CNS
por: Xiao, Yichuan, et al.
Publicado: (2015)

Dissecting the p53-Mdm2 feedback loop in vivo: uncoupling the role in p53 stability and activity
por: Pant, Vinod, et al.
Publicado: (2014)

Mdm2 overexpression and p73 loss exacerbate genomic instability and dampen apoptosis resulting in B-cell lymphoma
por: Riley, Maurisa F., et al.
Publicado: (2015)

Otud7b facilitates T cell activation and inflammatory responses by regulating Zap70 ubiquitination
por: Hu, Hongbo, et al.
Publicado: (2016)

Regulation of T-cell activation and migration by the kinase TBK1 during neuroinflammation
por: Yu, Jiayi, et al.
Publicado: (2015)

Heterozygous p53(V172F) mutation in cisplatin-resistant human tumor cells promotes MDM4 recruitment and decreases stability and transactivity of p53
por: Xie, Xiaolei, et al.
Publicado: (2016)

Epigenetic regulation of Il12 and Il23 gene expression and autoimmune inflammation by the deubiquitinase Trabid
por: Jin, Jin, et al.
Publicado: (2016)

Structural Basis of Competitive Recognition of p53 and MDM2 by HAUSP/USP7: Implications for the Regulation of the p53–MDM2 Pathway
por: Hu, Min, et al.
Publicado: (2006)

Diversification of dendritic cell subsets: Emerging roles for STAT proteins
por: Li, Haiyan S, et al.
Publicado: (2013)

A deficiency in Mdm2 binding protein (MTBP) inhibits Myc-induced B cell proliferation and lymphomagenesis
por: Odvody, Jessica, et al.
Publicado: (2010)

USP18 is crucial for IFN-γ-mediated inhibition of B16 melanoma tumorigenesis and antitumor immunity
por: Hong, Bangxing, et al.
Publicado: (2014)

TRAF3 regulates the effector function of regulatory T cells and humoral immune responses
por: Chang, Jae-Hoon, et al.
Publicado: (2014)

NF-κB inducing kinase maintains T cell metabolic fitness in antitumor immunity
por: Gu, Meidi, et al.
Publicado: (2021)

Otud7b controls noncanonical NF-κB activation via deubiquitination of TRAF3
por: Hu, Hongbo, et al.
Publicado: (2013)

Proinflammatory TLR signaling is regulated by a TRAF2-dependent proteolysis mechanism in macrophages
por: Jin, Jin, et al.
Publicado: (2015)

Effects of MDM2, MDM4 and TP53 Codon 72 Polymorphisms on Cancer Risk in a Cohort Study of Carriers of TP53 Germline Mutations
por: Fang, Shenying, et al.
Publicado: (2010)

WDR79 promotes the proliferation of non-small cell lung cancer cells via USP7-mediated regulation of the Mdm2-p53 pathway
por: Sun, Yang, et al.
Publicado: (2017)

STIP is a critical nuclear scaffolding protein linking USP7 to p53-Mdm2 pathway regulation
por: Ye, Mao, et al.
Publicado: (2015)

Targeting USP7-Mediated Deubiquitination of MDM2/MDMX-p53 Pathway for Cancer Therapy: Are We There Yet?
por: Qi, Si-Min, et al.
Publicado: (2020)

Peli1 promotes microglia-mediated CNS inflammation by regulating Traf3 degradation
por: Xiao, Yichuan, et al.
Publicado: (2013)

Benzimidazoles Downregulate Mdm2 and MdmX and Activate p53 in MdmX Overexpressing Tumor Cells
por: Mrkvová, Zuzana, et al.
Publicado: (2019)

USP9X destabilizes pVHL and promotes cell proliferation
por: Zhang, Cong, et al.
Publicado: (2016)

Impact of the MDM2 splice-variants MDM2-A, MDM2-B and MDM2-C on cytotoxic stress response in breast cancer cells
por: Huun, Johanna, et al.
Publicado: (2017)

Flap endonuclease 1 Facilitated Hepatocellular Carcinoma Progression by Enhancing USP7/MDM2-mediated P53 Inactivation
por: Bian, Saiyan, et al.
Publicado: (2022)

USP15 and USP4 facilitate lung cancer cell proliferation by regulating the alternative splicing of SRSF1
por: Das, Tanuza, et al.
Publicado: (2022)

TBK1 controls IgA class switching by negatively regulating noncanonical NF-κB signaling
por: Jin, Jin, et al.
Publicado: (2012)

Pharmacological inhibition of USP7 promotes antitumor immunity and contributes to colon cancer therapy
por: Fu, Changqing, et al.
Publicado: (2019)

USP53 plays an antitumor role in hepatocellular carcinoma through deubiquitination of cytochrome c
por: Yao, Ye, et al.
Publicado: (2022)

CDDO-Me reveals USP7 as a novel target in ovarian cancer cells
por: Qin, Dongjun, et al.
Publicado: (2016)

MDM2 antagonists boost antitumor effect of androgen withdrawal: implications for therapy of prostate cancer
por: Tovar, Christian, et al.
Publicado: (2011)

The Functional Roles of the MDM2 Splice Variants P2-MDM2-10 and MDM2-∆5 in Breast Cancer Cells
por: Huun, Johanna, et al.
Publicado: (2017)

Influence of MDM2 polymorphisms on squamous cell carcinoma susceptibility: a meta-analysis
por: Yu, Huanxin, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_dgtj5879venqqes7vsqb1u4553